Literature DB >> 26820376

Microglial polarization dynamics in dorsal spinal cord in the early stages following chronic sciatic nerve damage.

Fangting Xu1, Juan Huang2, Zhenghua He1, Jia Chen1, Xiaoting Tang1, Zongbin Song1, Qulian Guo1, Changsheng Huang3.   

Abstract

Peripheral nerve injury can lead to activation of spinal microglia, which can mediate neuroinflammation and contribute to neuropathic pain following nerve injury. Activated microglia may manifest with either pro-inflammatory M1 phenotype or anti-inflammatory M2 phenotype, which may lead to detrimental or beneficial roles in the nervous system. In this study, microglia numbers, morphology and gene profiles were examined in the dorsal spinal cord of rats over 14 days following sciatic nerve chronic constriction injury (CCI). The morphology of some microglia changed from a surveying to an activated state within 1 day of CCI. Neuropathic pain developed within seven to 14 days following injury and microglia numbers were increased, with almost all in the dorsal spinal cord morphologically defined as activated. At day one after CCI, both M1 and M2 microglia-related genes were increased but only M1 microglia-related genes remained elevated at day seven and 14 thereafter. These results indicate that both M1 and M2 microglia were activated in the dorsal spinal cord one day after CCI but the microglia skewed towards M1 phenotype during the following seven and 14 days.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  M1/M2 phenotype; Microglia; Nerve injury; Neuropathic pain

Mesh:

Substances:

Year:  2016        PMID: 26820376     DOI: 10.1016/j.neulet.2016.01.038

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  LRP1 deficiency in microglia blocks neuro-inflammation in the spinal dorsal horn and neuropathic pain processing.

Authors:  Coralie Brifault; HyoJun Kwon; Wendy M Campana; Steven L Gonias
Journal:  Glia       Date:  2019-02-11       Impact factor: 7.452

2.  Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189.

Authors:  Natalie M Guley; Nobel A Del Mar; Tyler Ragsdale; Chunyan Li; Aaron M Perry; Bob M Moore; Marcia G Honig; Anton Reiner
Journal:  Exp Eye Res       Date:  2019-03-26       Impact factor: 3.467

3.  The Role of Bone Morphogenetic Protein 4 in Microglial Polarization in the Process of Neuropathic Pain.

Authors:  Changqing Liu; Qi Sun; Junmei Xu; Weiyun Shen; Hui Li; Lin Yang
Journal:  J Inflamm Res       Date:  2022-05-03

4.  Central involvement of 5-HT1A receptors in antinociception induced by photobiomodulation in animal model of neuropathic pain.

Authors:  Gabriela Xavier Santos; Danillo Barbosa; Giovane Galdino de-Souza; Carolina Kosour; Nivaldo Antonio Parizotto; Luciana Maria Dos Reis
Journal:  Lasers Med Sci       Date:  2021-04-22       Impact factor: 3.161

5.  Microglia and Inhibitory Circuitry in the Medullary Dorsal Horn: Laminar and Time-Dependent Changes in a Trigeminal Model of Neuropathic Pain.

Authors:  Nuria García-Magro; Yasmina B Martin; Pilar Negredo; Francisco Zafra; Carlos Avendaño
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

6.  Salidroside attenuates neuroinflammation and improves functional recovery after spinal cord injury through microglia polarization regulation.

Authors:  Chenggui Wang; Qingqing Wang; Yiting Lou; Jianxiang Xu; Zhenhua Feng; Yu Chen; Qian Tang; Gang Zheng; Zengjie Zhang; Yaosen Wu; Naifeng Tian; Yifei Zhou; Huazi Xu; Xiaolei Zhang
Journal:  J Cell Mol Med       Date:  2017-11-17       Impact factor: 5.310

7.  Resveratrol Promotes Nerve Regeneration via Activation of p300 Acetyltransferase-Mediated VEGF Signaling in a Rat Model of Sciatic Nerve Crush Injury.

Authors:  Zhuofeng Ding; Jiawei Cao; Yu Shen; Yu Zou; Xin Yang; Wen Zhou; Qulian Guo; Changsheng Huang
Journal:  Front Neurosci       Date:  2018-05-23       Impact factor: 4.677

8.  Resveratrol enhances IL-4 receptor-mediated anti-inflammatory effects in spinal cord and attenuates neuropathic pain following sciatic nerve injury.

Authors:  Mu Xu; Zhigang Cheng; Zhuofeng Ding; Yunjiao Wang; Qulian Guo; Changsheng Huang
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.395

9.  Dehydrocorydaline attenuates bone cancer pain by shifting microglial M1/M2 polarization toward the M2 phenotype.

Authors:  Wenwen Huo; Ying Zhang; Yue Liu; Yishan Lei; Rao Sun; Wei Zhang; Yulin Huang; Yanting Mao; Chenchen Wang; Zhengliang Ma; Xiaoping Gu
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.395

Review 10.  Targeting the Microglial Signaling Pathways: New Insights in the Modulation of Neuropathic Pain.

Authors:  Katarzyna Popiolek-Barczyk; Joanna Mika
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.